PT-2026-3727 · Oracle · Oracle Life Sciences Central Coding+1

Published 2026-01-20 · Updated 2026-01-21 · CVE-2026-21980

Positive Technologies (AI Summary)

CVSS v3.1

6.5

Medium

Base vector

AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Name of the Vulnerable Software and Affected Versions Oracle Life Sciences Central Coding version 7.0.1.0

Description An easily exploitable issue exists in the Oracle Life Sciences Central Coding product, specifically within the Platform component. An unauthenticated attacker with network access via HTTP can compromise the system. Successful exploitation may lead to unauthorized modification, insertion, or deletion of data, as well as unauthorized read access to certain data within Oracle Life Sciences Central Coding.

Recommendations Update to a newer version that contains a fix for this vulnerability.

Fix

Related Identifiers

CVE-2026-21980

Affected Products

Oracle Life Sciences Central Coding

Xplatform

References · 5

• https://oracle.com/security-alerts/cpujan2026.html · Vendor Advisory
• https://nvd.nist.gov/vuln/detail/CVE-2026-21980 · Security Note
• https://osv.dev/vulnerability/CVE-2026-21980 · Vendor Advisory
• https://t.me/CVEtracker/42635 · Telegram Post
• https://twitter.com/CVEnew/status/2013740403544019194 · Twitter Post